Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York.
J Am Acad Dermatol. 2019 May;80(5):1199-1213. doi: 10.1016/j.jaad.2018.03.056. Epub 2018 Apr 14.
With increasing survival rates across all cancers, survivors represent a growing population that is frequently affected by persistent or permanent hair growth disorders as a result of systemic therapies, radiotherapy, surgical procedures, and therapeutic transplants. These hair disorders include persistent chemotherapy-induced alopecia, persistent radiotherapy-induced alopecia, endocrine therapy-induced alopecia and hirsutism, postsurgery alopecia and localized hypertrichosis, and persistent stem cell transplantation and targeted therapy-induced alopecia. The information contained in this continuing medical education series should facilitate a better understanding on hair disorders in cancer survivors so that adequate support and therapies may be provided.
随着所有癌症患者的生存率不断提高，幸存者的人数不断增加，他们经常受到系统性治疗、放疗、手术和治疗性移植的影响，出现持续性或永久性的毛发生长障碍。这些毛发疾病包括持续性化疗引起的脱发、持续性放疗引起的脱发、内分泌治疗引起的脱发和多毛症、手术后脱发和局部性多毛症、以及持续性干细胞移植和靶向治疗引起的脱发。本继续教育系列中包含的信息应有助于更好地理解癌症幸存者的毛发疾病，以便提供足够的支持和治疗。
